Skip to main content
Top
Published in: Supportive Care in Cancer 8/2018

01-08-2018 | Original Article

Maximizing patient adherence to prehabilitation: what do the patients say?

Authors: Vanessa Ferreira, Ramanakumar V. Agnihotram, Andreas Bergdahl, Stefanus J. van Rooijen, Rashami Awasthi, Francesco Carli, Celena Scheede-Bergdahl

Published in: Supportive Care in Cancer | Issue 8/2018

Login to get access

Abstract

Purpose

Multimodal prehabilitation programs (exercise, nutrition, and anxiety reduction) have been shown to be successful for enhancing patients’ physical function prior to surgery, although adherence remains a challenge. Given the short pre-operative period, maintaining adherence is critical to maximize program effectiveness. This study was designed to better understand patients’ perspectives of prehabilitation and to identify factors related to program adherence.

Methods

A qualitative descriptive study was conducted based on 52 cancer patients enrolled in a prehabilitation program at the Montreal General Hospital, Montreal, Canada. Data was collected with a structured questionnaire designed to evaluate the program.

Results

Patients enjoyed their experience in prehabilitation, especially the exercise program and training sessions. The primary motivating factor for participation was to be physically prepared for the surgery. The most challenging exercise component was resistance training, while the most enjoyed was the aerobic training. Approximately 50% of patients were interested in group fitness classes as opposed to supervised individual training sessions for reasons related to social support. The preferred methods for exercise program delivery were home-based and one supervised exercise session per week. The biggest barrier to participation was related to transportation.

Conclusions

These findings highlight the need to make prehabilitation programs more patient-centered. This is critical when designing more effective therapeutic strategies tailored to meet patients’ specific needs while overcoming program non-adherence.
Literature
5.
go back to reference Feldman LS, Delaney CP, Ljungqvist O, Carli F, Surgeons, & S. of A. G. E (2015) The SAGES/ERAS Society manual of enhanced recovery programs for gastrointestinal surgery, 1st edn. Springer, ChamCrossRef Feldman LS, Delaney CP, Ljungqvist O, Carli F, Surgeons, & S. of A. G. E (2015) The SAGES/ERAS Society manual of enhanced recovery programs for gastrointestinal surgery, 1st edn. Springer, ChamCrossRef
6.
go back to reference Mayo N, Feldman L, Scott S, Zavorsky G, Kim D, Charlebois P, Stein B, Carli F (2011) Impact of preoperative change in physical function on postoperative recovery: argument supporting prehabilitation for colorectal surgery. Surgery 150(3):505–514CrossRefPubMed Mayo N, Feldman L, Scott S, Zavorsky G, Kim D, Charlebois P, Stein B, Carli F (2011) Impact of preoperative change in physical function on postoperative recovery: argument supporting prehabilitation for colorectal surgery. Surgery 150(3):505–514CrossRefPubMed
12.
go back to reference Li C, Carli F, Lee L, Charlebois P, Stein B, Liberman AS, Kaneva P, Augustin B, Wongyingsinn M, Gamsa A, Kim DJ, Vassiliou MC, Feldman LS (2013) Impact of a trimodal prehabilitation program on functional recovery after colorectal cancer surgery: a pilot study. Surg Endosc Other Interv Techn 27(4):1072–1082. https://doi.org/10.1007/s00464-012-2560-5 CrossRef Li C, Carli F, Lee L, Charlebois P, Stein B, Liberman AS, Kaneva P, Augustin B, Wongyingsinn M, Gamsa A, Kim DJ, Vassiliou MC, Feldman LS (2013) Impact of a trimodal prehabilitation program on functional recovery after colorectal cancer surgery: a pilot study. Surg Endosc Other Interv Techn 27(4):1072–1082. https://​doi.​org/​10.​1007/​s00464-012-2560-5 CrossRef
Metadata
Title
Maximizing patient adherence to prehabilitation: what do the patients say?
Authors
Vanessa Ferreira
Ramanakumar V. Agnihotram
Andreas Bergdahl
Stefanus J. van Rooijen
Rashami Awasthi
Francesco Carli
Celena Scheede-Bergdahl
Publication date
01-08-2018
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 8/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4109-1

Other articles of this Issue 8/2018

Supportive Care in Cancer 8/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine